Islet autoimmunity is highly prevalent and associated with diminished β-cell function in patients with type 2 diabetes in the Grade Study 2022

Preserved insulin secretory capacity and weight loss are the predominant predictors of glycemic control in patients with type 2 diabetes randomized to roux-en-Y gastric bypass 2015

A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women 2012

Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy 1985

Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII 1985

Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion 1985

Better care strategies are necessary to address poor medication adherence [abstract] 2020

Change in A1C with and without intermittent use of CGM in adults with type 2 diabetes participating in the Onduo Virtual Diabetes Clinic [abstract] 2020

Cross-study comparisons done right: an illustration using two pivotal trials of closed-loop systems [abstract] 2020

Derived time-in-range is associated with MACE in T2D: data from the DEVOTE Trial [abstract] 2020

Differences in chronic kidney disease management in patients with and without diabetes in a large care delivery system [abstract] 2020

First home evaluation of the Omnipod Horizon automated glucose control system at specific glucose targets in children with type 1 diabetes [abstract] 2020

Freestyle Libre system use is associated with reduction in inpatient and outpatient emergency acute diabetes events and all-cause hospitalizations in patients with type 2 diabetes [abstract] 2020

Glycemic relapse: major threat to ongoing improvement in diabetes care [abstract] 2020

Patient-reported outcomes for 2,335 adults with type 2 diabetes using the omnipod insulin management system show glycemic improvement over first 90 days of use [abstract] 2020

Patients’ interpretation of Ambulatory Glucose Profile (AGP), CGM, and pump reports [abstract] 2020

Safety and glycemic outcomes of the MiniMed advanced hybrid closed-loop (AHCL) system in subjects with T1D [abstract] 2020

Ultra-Rapid Lispro (URLi) demonstrates similar time-in-target range to Humalog with the Medtronic MiniMed 670G Hybrid Closed-Loop System [abstract] 2020

Utilization of continuous glucose monitors is associated with reduction in inpatient and outpatient emergency acute diabetes events regardless of prior blood test strip usage [abstract] 2020

A comparison of the impact of the 2017 ACC/AHA hypertension guidelines on primary care populations with and without diabetes [abstract] 2018

Alogliptin in triple therapy with metformin and sulfonylureas provides significant reductions in HbA1c and is well tolerated: an analysis from the EXAMINE Trial [abstract] 2016

Can financial incentives prevent diabetes in a low-income population? [abstract] 2016

Comparative effectiveness of two diabetes clinical decision support systems on cardiometabolic outcomes and CV risk: randomized trial [abstract 2304-PUB] 2016

Designing outpatient diabetes care clinical decision support systems for high use rates [abstract 2309-PUB] 2016

Double-blind mealtime faster-acting insulin aspart vs. insulin aspart in basal-bolus improves glycemic control in T1D: the Onset 1 Trial [abstract #293-OR] 2016

Effect of empagliflozin on nephropathy in subgroups by age: results from EMPA-REG outcome [abstract 1198-P] 2016

Efficacy and safety of LixiLan vs. insulin glargine according to baseline characteristics in patients with type 2 diabetes from the LixiLan-L Trial [abstract 1018-P] 2016

Efficacy and safety of the insulin glargine plus lixisenatide fixed-ratio combination vs. insulin glargine in patients wth T2DM: the LixiLan-L trial [abstract] 2016

Eliciting patient treatment preferences using a clinical decision support system [abstract 1252-P] 2016

Hypoglycemia is associated with increased risk of cardiovascular events: results from the EXAMINE Trial [abstract] 2016

Long-term impact of intensive glucose, blood pressure, or lipid control on health utility: ACCORDION Study [abstract] 2016

Mortality findings from the EXAMINE Trial [abstract] 2016

Overuse and underuse of aspirin for primary prevention [abstract 1225-P] 2016

Are composite measures of diabetes quality of care associated with major CV events [abstract 440-P]? 2015

Disseminating web-based EHR-linked diabetes clinical decision support system from one medical group to another: case study [abstract 1377-P] 2015

Early response to liraglutide 3.0 mg in adults with overweight or obesity and type 2 diabetes: subanalysis of the SCALE Diabetes Trial [abstract] 2015

Evaluation of provider experience with an EHR-based clinical decision support tool [abstract] 2015

Factors associated with reduced hypoglycemia awareness (RHA) in older adults with type 1 diabetes (T1D) [abstract] 2015

Glucose variability in type 2 diabetes: the initial results of the FLAT-SUGAR trial [abstract 385-OR] 2015

Glycemic variability correlated with 1.5-anhydroglucitol (1.5 AHG) but not with markers of oxidation, inflammation, and endothelial function: baseline characteristics of the CAROLINA CGM sub-study [abstract] 2015

How to minimize future CV events and total mortality in adults with diabetes: lessons from the 10,000,000 person-year SUPREME Cohort Study [abstract] 2015

Hypoglycemia and glucose variability in older adults with type 1 diabetes (T1D) [abstract 408-P] 2015

Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract] 2015

Severe hypoglycemia in a large cohort of adults with diabetes mellitus treated in U.S. integrated health care delivery systems, 2005-2011 [abstract 390-P] 2015

Superior reduction of HbA1c in a double-blind, randomized study of basal insulin peglispro (BIL) vs. insulin glargine (GL) in patients (pts) with T1D: IMAGINE 3 [abstract] 2015

Surveillance of cardiovascular events and total mortality among insured adults with and without diabetes: the SUPREME Cohort Study [abstract 55-OR] 2015

Sustained use of a diabetes clinical decision support tool in primary care practices [abstract] 2015

Trends in diabetes control and insulin use in the U.S., 1998-2010 [abstract] 2015

Educating resident physicians using virtual case-based simulation improves diabetes management--a randomized, controlled trial [abstract 322-OR] 2014

Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes [abstract] 2014

Costs associated with delivering intensive or standard glucose, lipids, and systolic blood pressure control strategies in the ACCORD Trial [abstract] 2013

Glucose screening and identification of pre-diabetes in children and adolescents 2007-2011 [abstract] 2013

Virtual diabetes education improves resident physician knowledge and performance: a cluster-randomized trial [abstract] 2013

Weight loss and metabolic response to a commercial weight loss program in type 2 diabetes [abstract] 2013

Are outcomes from diabetes self-management education sustained? A randomized controlled trial [abstract] 2012

Diabetes prevalence among 7 million adult HMO members, 2005-2009: The SUPREME-DM Project [abstract] 2012

Five-year incidence of diabetes among 6.7 million adult HMO members: the SUPREME-DM Project [abstract] 2012

Intensive glucose, blood pressure, or lipid control had no significant negative impact on health utility or quality-adjusted life years in the ACCORD Trial [abstract] 2012

Simulated diabetes training helps providers bring patients to goals: a cluster randomized trial [abstract] 2012

Simulated training improves provider knowledge and confidence in managing diabetes [abstract] 2012

A comparison of group and individual education for patients with sub-optimally controlled type 2 diabetes: a randomized controlled trial [abstract 232-OR] 2011

Early initiation of metformin in new-onset type 2 diabetes [abstract] 2011

Effect of intensive versus standard blood pressure control on health-related quality of life in type 2 diabetes mellitus: ACCORD Trial [abstract 47-OR] 2011

Impact of bariatric surgery on long-term remission and relapse of type 2 diabetes mellitus: multi-site study [abstract 1190-P] 2011

Intensive glycemic control and fracture risk [abstract 1352-P] 2011

Intensive glycemic control not linked to falls in ACCORD [abstract] 2011

Major depression predicts total mortality in ACCORD trial participants [abstract 48-OR] 2011

Overweight and obesity in those age 3-17 years old: implications for diabetes prevention [abstract 2377-PO] 2011

Personalization of care for type 2 diabetes: a process control approach [abstract] 2011

Prioritization of treatment and its consequences: implications of accountability measures [abstract 46-OR] 2011

Reversibility of fenofibrate-induced renal function impairment in ACCORD type 2 diabetic participants [abstract] 2011

The relationship between depression and completion of recommended self-management education [abstract 752-P] 2011

A diabetes simulated physician learning program improved glucose control and is highly cost-effective [abstract] 2010

A new approach to CME? A simulated physician learning program improves glucose control in adults with diabetes [abstract] 2010

Cost-effectiveness of an EMR-based diabetes clinical decision support system [abstract] 2010

Hypertension treatment intensification and BP control in adults with and without diabetes [abstract] 2010

Identifying physician decision stretegies for treating patients with type 2 diabetes [abstract] 2010

Personalized learning intervention to enhance hypertension care skills of physicians and extended-care providers [abstract] 2010

Short-term results of a randomized clinical trial of diabetes education on patient empowerment and psychological attributes [abstract] 2010

Standardized vs personalized diabetes care goals: implications for guidelines, decision support, and accountability measures [abstract] 2010

The relationship between depression and attitudes, self-efficacy, self-care adherence and A1c in patients with suboptimally controlled diabetes [abstract] 2010

Towards lower macrovascular risk in diabetes patients: a simulation-based evaluation of prioritization strategies [abstract] 2010

Validation of the SimCare model: a computational model of individual patients with type 2 diabetes [abstract] 2010

Attitudes toward diabetes correlate with self-efficacy, clinical and behavioral outcomes [abstract] 2009

Disease management strategies to optimize cardiovascular risk in type 2 diabetes mellitus [abstract] 2009

EMR-based clinical decision support system improved glucose and blood pressure control in adults with diabetes [abstract] 2009

How do the best physicians get diabetes patients to glycemic goals [abstract]? 2009

Personalized physician learning intervention improved glucose control in adults with diabetes [abstract] 2009

Are diabetes patients with depression more likely to get routine care process measures [abstract]? 2008

Association of lean mass and fat mass with bone mineral density in older diabetic adults: the ACCORD-BONE study [abstract] 2008

How do the best physicians get diabetes patients to glycemic goals [abstract]? 2008

Implementation of electronic decision support for providers to improve diabetes care [abstract] 2008

Reasons for diabetes clinical inertia in primary care practice [abstract] 2008

The anatomy of clinical inertia: using EMR-derived data to profile 21 physician-specific medication treatment strategies in diabetes care [abstract] 2008

Using EMR (electronic medical record) data for passive patient safety surveillance in clinical trials [abstract] 2008

Using natural language processing (NLP) to identify depression in diabetes patients [abstract] 2008

Correlation between provider use rates of a clinical decision support tool and diabetes performance measures [e-poster 1266-P] 2016

0012-1797

1939-327X